Moa Fransson

Holds a PhD in gene and immunotherapy and a vast experience in coaching startup companies and entrepreneurs from Uppsala University and in Europe within EITHealth. Previous experience from pre-clinical development in bladder cancer gene therapy and CAR-T cell treatments, co-founder of a startup for medical devices and receiver of several awards in the field of pre-clinical research and commercialization.